Lactylation-related gene signature accurately predicts prognosis and immunotherapy response in gastric cancer
The risk model not only provides a basis for better prognosis in GC patients, but also is a potential prognostic indicator to distinguish the molecular and immune characteristics, and the response from Immune checkpoint inhibitors (ICI) therapy and chemotherapy in GC.
Authors
- Haifeng Dong (ORCID: https://orcid.org/0000-0003-2832-0973)
- Changhua Zhang (ORCID: https://orcid.org/0000-0003-4358-4096)
- Rishun Su
- Xuezeng Sun
- Wenchao Li (ORCID: https://orcid.org/0000-0002-3078-1421)
- Jingyao Chen (ORCID: https://orcid.org/0000-0002-4934-7983)
- Songcheng Yin
Institutions
- Sun Yat-sen University (CN)
- The Seventh Affiliated Hospital of Sun Yat-sen University (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-11-28
- DOI
- https://doi.org/10.3389/fonc.2024.1485580
- Citations
- 14
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 3.96
Funders
- Sanming Project of Medicine in Shenzhen